Kansas House Bill HB2730

Kansas 2025-2026 Regular Session

• Introduced: 2/5/26
• Refer: 2/5/26

Caption

Requiring managed care organizations to provide an explanation of benefits to KanCare and CHIP enrollees.

Summary

HB 2730 would amend Kansas medical assistance law to impose additional requirements on managed care organizations (MCOs) serving KanCare and CHIP enrollees and the providers who treat them. The bill requires MCOs to give healthcare providers more detailed denial documentation, including specific reasons for denials and standardized remark codes, and to offer quarterly in-person training and education on billing, reimbursement, and program policies. It also directs the secretary of health and environment to establish uniform standards for provider enrollment, credentialing, prior authorization, grievance and appeal processes, and other administrative procedures used by MCOs. The bill further requires annual independent audits of claims paid and denied by MCOs and their subcontractors, with authority to require payment of claims found to have been wrongly denied and to assess liquidated damages and audit costs. It also includes protections for nursing facilities during re-credentialing after ownership changes and prohibits MCO discrimination against qualified pharmacies and pharmacists within their service areas. Beginning January 1, 2028, MCOs would have to send enrollees an explanation of benefits, digitally or by mail, showing key claim information such as provider name, service date, billed amount, allowed amount, and amount paid by the program.

Impact

HB 2730 would expand the regulatory duties of the Kansas Department of Health and Environment and the managed care organizations operating under KanCare and CHIP. It would create new provider-facing disclosure, training, and appeals requirements, establish standardized administrative processes, and add audit and enforcement mechanisms that could increase oversight and compliance obligations for MCOs and their subcontractors. The bill would also affect pharmacies, pharmacists, nursing facilities, and healthcare providers by strengthening participation and reimbursement-related protections, while giving enrollees a new explanation-of-benefits notice starting in 2028.

Sentiment

Based on the bill’s structure and caption, the measure appears generally supportive of providers and enrollees by increasing transparency, standardizing procedures, and improving access to billing and claims information. The absence of recorded committee testimony or votes means there is no direct evidence of formal support or opposition in the provided materials, but the bill’s provisions suggest a consumer- and provider-protective policy approach rather than a cost-containment one.

Contention

The likely points of contention are the administrative and financial burdens placed on managed care organizations, including mandatory quarterly trainings, standardized processes, annual independent audits, and potential liquidated damages for delayed appeal resolution. MCOs may also object to the bill’s restrictions on prior authorization, retrospective utilization review, and pharmacy network participation requirements, as these provisions limit plan flexibility. Providers and nursing facilities are likely to favor the bill’s transparency and payment protections, while insurers and MCOs may view it as increasing regulatory oversight and operational costs.